Patents expiring in 2031

US 7956054

Dual-acting pyrazole antihypertensive agents

Theravance, Inc. · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7955596

B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production

UNIVERSITY OF CONNECTICUT · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7956220

MAO-B inhibitors useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2724937

MEDICAMENT POUR LE TRAITEMENT DES ULCERES GASTRO-INTESTINAUX

BIOCODEX [FR] · Granted Wed Jun 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jun 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7959925

Trimeric OX40-immunoglobulin fusion protein and methods of use

Providence Health System · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960372

Bivalent Smac mimetics and the uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960385

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960415

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7959934

Method for rapid generation of mature dendritic cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960348

Metastin derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960383

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

Laboratories Almirall, S.A. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960384

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960502

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960505

Lantibiotics and uses thereof

Regents of the University of Minnesota · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7959923

Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

The Regents of the University of California · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7959929

Materials and methods for respiratory disease control in canines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960535

Recombinant lipidated PsaA protein, methods of preparation and use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960356

Oligodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960605

Methods for testing for caloric restriction (CR) mimetics

BioMarker Pharmaceuticals, Inc. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960133

Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

The Board of Regents of the University of Texas System · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960369

Receptor function regulator

Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960586

Purification of armodafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960416

Stable emulsion composition

Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960606

Mouse model of chronic heart failure and coronary atherosclerosis regression

The Regents of the University of California · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7960398

Regulation of TNF-alpha

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2784005

SYSTEMES DE VEHICULES NANOPARTICULAIRES A BASE DE POLY (ACIDE DL-LACTIQUE - CO - GLYCOLIQUE) (PLGA) POUR THERAPIE PHOTODYNAMIQUE (PDT)

BIOLITEC PHARMA MARKETING LTD [MY] · Granted Thu Jun 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2011142948

Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy

BIOLITEC INC [DE] · Granted Thu Jun 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964186

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964217

Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor

Nektar Therapeutics · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964187

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964748

Process for preparing intermediates of HMG-CoA reductase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964591

Pyridazine derivatives and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964615

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor

Almirall, S.A. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964576

Anti-arthropod vector vaccines, methods of selecting and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964624

Inhibitors of serine proteases

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964559

MVL, an antiviral protein from a cyanobacterium

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964561

Protein formulations for use at elevated temperatures

Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964702

Phalloidin derivatives and methods for their synthesis

The Regents of the University of California · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964188

Use of placental alkaline phosphatase to promote skin cell proliferation

Essential Skincare, LLC · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964377

Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964730

Amino-substituted ethylamino β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964710

EML4-ALK fusion gene

CUREGENE K.K. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964646

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964590

Cyclopamine lactam analogs and methods of use thereof

Infinity Discovery, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964612

Therapeutic pyrazolyl thienopyridines

Graceway Pharmaceuticals. LLC · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964573

Regulating expression of transient receptor potential channel genes

The Regents of the University of California · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964359

Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance

Acumen Pharmaceuticals, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7964712

Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains

The Regents of the University of California · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)